Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Dexmedetomidine in Total Hip Arthroplasty
NCT07743853Recruiting
- Sponsor
- Poznan University of Medical Sciences
- Start
- Aug 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in hip osteoarthritis (3 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Systemic Immune-Inflammation Index at 24 hours. Started Aug 2026; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NCT07743853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07743853.